| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 605,550 | 624,746 | 604,086 | 520,686 | | Cost of Revenue | 473,965 | 731,825 | 383,546 | 375,782 | | | Gross Profit | 131,585 | (107,079) | 220,540 | 144,904 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 76,137 | (182,340) | 155,246 | 81,325 | | Non Recurring |
-
| (2,836) | 838 | 43,659 | | Others | 27,191 | 33,484 | 27,384 | 23,827 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 28,257 | 44,613 | 37,072 | (3,907) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 2,948 | 1,316 | 3,437 | | Earnings Before Interest And Taxes | 30,489 | 47,561 | 38,388 | (470) | | Interest Expense | 27,316 | 8,986 | 9,684 | 10,820 | | Income Before Tax | 3,173 | 38,575 | 28,704 | (11,290) | | Income Tax Expense | 1,619 | 12,942 | 9,668 | 10,557 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,611 | (4,355) | 21,024 | (24,185) | | | Non-recurring Events | | Discontinued Operations | 3,161 | (199) | (12,171) | (119,066) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,772 | (4,554) | 8,853 | (143,251) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,772 | ($4,554) | $8,853 | ($143,251) |
|
0.31% Nasdaq 
0.13%
Income Statement
